Sulfato de hidrazina (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sulfato de hidrazina" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

low place

4^th place

8^th place

1^st place

2^nd place

4^th place

8,869^th place

low place

aacrjournals.org

Chlebowski, R. T.; Bulcavage, L.; Grosvenor, M.; et al. (1987), «Hydrazine Sulfate in Cancer Patients With Weight Loss. A Placebo-Controlled Clinical Experience», Cancer, 59 (3): 406–10, PMID 3791153, doi:10.1002/1097-0142(19870201)59:3<406::AID-CNCR2820590309>3.0.CO;2-W, consultado em 9 de abril de 2014, cópia arquivada em |arquivourl= requer |arquivodata= (ajuda) 🔗 .
Chlebowski, R. T.; Bulcavage, L.; Grosvenor, M.; Oktay, E.; Block, J. B.; Chlebowski, J. S.; Ali, I.; Elashoff, R. (1990), «Hydrazine Sulfate Influence on Nutritional Status and Survival in Non-Small-Cell Lung Cancer», Journal of Clinical Oncology, 8 (8): 9–15, PMID 1688616, consultado em 9 de abril de 2014, cópia arquivada em |arquivourl= requer |arquivodata= (ajuda) 🔗 .
Gold, J. (1999), «Long term complete response in patient with advanced, localized NSCLC with hydrazine sulfate, radiation and Carboplatin, refractory to combination chemotherapy», Proceedings of the American Association for Cancer Research (40) . Abstract. Arquivado em 3 de março de 2016, no Wayback Machine.

Chlebowski, R. T.; Bulcavage, L.; Grosvenor, M.; et al. (1987), «Hydrazine Sulfate in Cancer Patients With Weight Loss. A Placebo-Controlled Clinical Experience», Cancer, 59 (3): 406–10, PMID 3791153, doi:10.1002/1097-0142(19870201)59:3<406::AID-CNCR2820590309>3.0.CO;2-W, consultado em 9 de abril de 2014, cópia arquivada em |arquivourl= requer |arquivodata= (ajuda) 🔗 .
Brauer, M.; Inculet, R. I.; Bratnager, G.; Marsh, G. D.; Driedger, A. A.; Thompson, R. T. (1994), «Insulin Protects against Hepatic Bioenergetic Deterioration by Cancer Cachexia. An in-Vivo ³¹P Magnetic Resonance Study», Cancer Research, 54 (24): 6383–86, PMID 7987832 .
Chlebowski, R. T.; Bulcavage, L.; Grosvenor, M.; Oktay, E.; Block, J. B.; Chlebowski, J. S.; Ali, I.; Elashoff, R. (1990), «Hydrazine Sulfate Influence on Nutritional Status and Survival in Non-Small-Cell Lung Cancer», Journal of Clinical Oncology, 8 (8): 9–15, PMID 1688616, consultado em 9 de abril de 2014, cópia arquivada em |arquivourl= requer |arquivodata= (ajuda) 🔗 .

Chlebowski, R. T.; Bulcavage, L.; Grosvenor, M.; et al. (1987), «Hydrazine Sulfate in Cancer Patients With Weight Loss. A Placebo-Controlled Clinical Experience», Cancer, 59 (3): 406–10, PMID 3791153, doi:10.1002/1097-0142(19870201)59:3<406::AID-CNCR2820590309>3.0.CO;2-W, consultado em 9 de abril de 2014, cópia arquivada em |arquivourl= requer |arquivodata= (ajuda) 🔗 .
Chlebowski, R. T.; Bulcavage, L.; Grosvenor, M.; Oktay, E.; Block, J. B.; Chlebowski, J. S.; Ali, I.; Elashoff, R. (1990), «Hydrazine Sulfate Influence on Nutritional Status and Survival in Non-Small-Cell Lung Cancer», Journal of Clinical Oncology, 8 (8): 9–15, PMID 1688616, consultado em 9 de abril de 2014, cópia arquivada em |arquivourl= requer |arquivodata= (ajuda) 🔗 .
Gold, J. (1999), «Long term complete response in patient with advanced, localized NSCLC with hydrazine sulfate, radiation and Carboplatin, refractory to combination chemotherapy», Proceedings of the American Association for Cancer Research (40) . Abstract. Arquivado em 3 de março de 2016, no Wayback Machine.